No gender difference was found in the reduction in LEDD (p=0.958, Cohen’s d=0.15) nor in the mean dose reduction in PD medication types, except for a greater reduction in male COMT inhibitors dose (p=0.043, Cohen’s d=0.363). Here, COMT is linked to Parkinson disease.